Pulmonary hypertension due to fibrotic lung disease: hidden value in a neutral trial

Am J Respir Crit Care Med. 2014 Jul 15;190(2):131-2. doi: 10.1164/rccm.201406-1094ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Idiopathic Interstitial Pneumonias / complications*
  • Male
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Sulfonamides
  • Bosentan